What is the appropriate work-up for hematuria in a patient who has recently started anticoagulation (anticoagulant) therapy?

Work-up for Hematuria After Starting Anticoagulation

Hematuria in patients on anticoagulation mandates full urological evaluation regardless of anticoagulation status, as 25-30% of these patients harbor significant underlying pathology including malignancy in approximately 25% of cases. 1, 2, 3

Initial Assessment and Classification

Determine Bleeding Severity

First, classify whether the hematuria represents major or non-major bleeding using these criteria 4:

Major bleeding if ≥1 of the following applies:

• Hemodynamic instability 4
• Hemoglobin decrease ≥2 g/dL 4
• Requirement of ≥2 units of red blood cells 4

Non-major bleeding if none of the above criteria are met 4

Immediate Laboratory Work-up

• Complete blood count with hemoglobin and platelets 5
• Prothrombin time/INR and activated partial thromboplastin time 5
• Type and cross-match blood 5
• Urinalysis to confirm hematuria and assess for clots 1

Anticoagulation Management

For Non-Major Hematuria

• Continue anticoagulation if bleeding is minimal and patient is hemodynamically stable 4
• Provide local therapy and supportive care 4
• Do not routinely reverse anticoagulation for non-major bleeding 6

For Major Hematuria

• Stop oral anticoagulant immediately 4, 1
• If on warfarin (VKA), administer 5-10 mg IV vitamin K 4
• If on DOAC, do not administer reversal agents unless bleeding is life-threatening 4
• Provide supportive care and volume resuscitation 4
• Stop concomitant antiplatelet agents if applicable 4

Mandatory Urological Investigation

Critical principle: Do not attribute hematuria solely to anticoagulation without investigation, as this delays diagnosis of malignancy in up to 10% of cases and other significant pathology in 30% of patients. 6, 2, 3

Complete Urological Work-up Required

Perform the following evaluations once patient is stabilized 5, 7, 8:

• Cystoscopy - identifies bladder tumors, hemorrhagic cystitis, prostatic bleeding 7, 8
• Upper tract imaging - CT urography or IV urography to evaluate kidneys and ureters 7
• Renal ultrasound - can be used as alternative imaging modality 8

Expected Findings

Studies show significant pathology in anticoagulated patients with hematuria includes 2, 3, 8:

• Urinary tract malignancy: 7-25% of patients 3, 8
• Nephrolithiasis: common finding 2, 3
• Benign prostatic hyperplasia: frequent in men 2, 8
• Hemorrhagic cystitis: particularly in aspirin users 8
• Renal infarction, infection, or structural abnormalities 2

Timing of Urological Evaluation

• Perform cystoscopy and imaging after bleeding is controlled and patient is stable 5
• Do not delay investigation beyond initial stabilization period 3, 8
• Investigation should occur even if anticoagulation parameters were therapeutic when hematuria developed 9

Common Pitfalls to Avoid

• Never assume hematuria is simply due to anticoagulation without full urological work-up - this misses malignancy in 25% of cases 1, 6, 2
• Do not perform only upper tract imaging without cystoscopy - bladder pathology accounts for significant findings 7, 8
• Avoid delaying evaluation in patients with "excessive" anticoagulation - tumors are still found in 18% of over-anticoagulated patients 8
• Do not skip evaluation in microscopic hematuria - significant pathology found in 50% of these cases 3

Restarting Anticoagulation After Work-up

Once source is identified and controlled 4, 1:

• Hold anticoagulation minimum 24-48 hours after complete cessation of gross hematuria 1
• Extend hold to 48-72 hours for severe bleeding or in elderly patients (>80 years) 1
• Resume at usual therapeutic dose once hemostasis confirmed and no contraindication exists 1
• Consider switching from warfarin/heparin to LMWH or DOACs to reduce recurrence risk 9